Nanomedicine: Nanotechnology, Biology, and Medicine
Journal Title
Nanomedicine: Nanotechnology, Biology, and Medicine
ISSN
E 1549-9642 | P 1549-9634 | 1549-9642 | 1549-9634
Publisher
Elsevier BV
Elsevier
Listed on(Coverage)
JCR
2009-2019
SJR
2006-2019
CiteScore
2011-2019
SCIE
2010-2021
SCOPUS
2017-2020
MEDLINE
2016-2021
EMBASE
2016-2020
Active
Active
based on the information
SCOPUS:2020-10
Country
NETHERLANDS
Aime & Scopes
The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.
Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.
Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories.